Study of Tarceva and Targretin in Stage I-II Lung Cancer

NCT00125372 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Carcinoma, Non-small-cell Lung

Interventions

DRUG: erlotinib (Tarceva) and bexarotene (Targretin)

Sponsor

Dartmouth-Hitchcock Medical Center

Collaborators

[object Object]
[object Object]